Nexstim
14.10 EUR
-0.70 %
5,597 following
NXTMH
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
Valuation
Income statement
Quarterly estimates
Valuation
P/E (adj.)
Median 2020-2024
EV/S
Median 2020-2024
EV/EBIT (adj.)
Median 2020-2024
Dividend yield
Median 2020-2024
P/B
Median 2020-2024
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price (EUR) | 0.60 | 0.12 | 0.10 | 4.78 | 4.00 | 2.69 | 7.90 | 14.10 | 14.10 | 14.10 | 14.10 |
| Shares | 3.3 | 62.8 | 439.6 | 7.3 | 7.3 | 7.3 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 |
| Market cap | 2.0 | 7.5 | 43.1 | 34.8 | 29.1 | 19.6 | 56.6 | 101.0 | 101.0 | 101.0 | 101.0 |
| Enterprise value | 3.0 | 9.5 | 44.7 | 33.5 | 28.1 | 22.5 | 61.4 | 103.1 | 98.5 | 93.3 | 87.2 |
| EV/S | 1.1 | 2.9 | 10.9 | 5.2 | 3.0 | 3.1 | 7.0 | 6.6 | 5.4 | 4.6 | 3.7 |
| EV/EBITDA | neg. | neg. | neg. | neg. | 21.4 | neg. | 189.9 | 19.8 | 16.4 | 13.6 | 11.0 |
| EV/EBIT (adj.) | neg. | neg. | neg. | neg. | 33.6 | neg. | neg. | 24.3 | 21.0 | 16.6 | 13.1 |
| EV/EBIT | neg. | neg. | neg. | neg. | 33.6 | neg. | neg. | 24.3 | 21.0 | 16.6 | 13.1 |
| P/E (adj.) | neg. | neg. | neg. | neg. | 22.2 | neg. | neg. | 25.0 | 22.5 | 18.3 | 17.1 |
| P/E | neg. | neg. | neg. | neg. | 22.2 | neg. | neg. | 25.0 | 22.5 | 18.3 | 17.1 |
| P/B | neg. | neg. | neg. | 10.9 | 7.1 | 6.9 | 15.0 | 12.9 | 8.2 | 5.7 | 4.3 |
| P/S | 0.7 | 2.3 | 10.5 | 5.4 | 3.1 | 2.7 | 6.5 | 6.4 | 5.5 | 5.0 | 4.2 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 1.5 % |
| Equity ratio | -3.0 % | -9.7 % | -23.5 % | 31.9 % | 39.8 % | 28.6 % | 26.7 % | 46.1 % | 70.0 % | 76.6 % | 79.7 % |
| Gearing ratio | -371.7 % | -271.7 % | -108.1 % | -40.6 % | -23.4 % | 105.6 % | 127.9 % | 26.7 % | -20.2 % | -43.2 % | -57.9 % |